Medical Equipment

Global Implantable Cardiac Devices Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the implantable cardiac devices market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Implantable Cardiac Devices Market Size Today And What Will Its Value Be At The End Of 2029?

The implantable cardiac devices market has demonstrated robust expansion in recent years. This market is projected to grow from $12.34 billion in 2024 to $13.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. The expansion observed in prior periods can be attributed to advancements in medical technology, the increasing prevalence of cardiovascular diseases, a growing aging population, enhancements in device reliability and longevity, rising awareness, and the early diagnosis of heart conditions.

The implantable cardiac devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $18.69 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.8%. During the projected period, this expansion can be linked to factors such as ongoing technological progress enhancing device capabilities, a rising preference for less invasive surgical techniques, an expanding elderly demographic, increasing healthcare spending, and improvements in healthcare facilities within developing regions. Key developments expected during this timeframe encompass the incorporation of digital health solutions and remote patient monitoring, the creation of advanced devices offering superior functionalities, an increase in customized cardiac treatments tailored to individual patients, a focus on economical and value-driven healthcare models, and a greater emphasis on preventive heart care and prompt medical intervention.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19097&type=smp

Which Key Drivers Are Powering Growth In The Implantable Cardiac Devices Market?

The increasing occurrence of heart diseases is projected to propel the expansion of the implantable cardiac devices market. This rise in heart ailments can be attributed to the growing prevalence of risk factors, including poor diet, sedentary lifestyle, obesity, and chronic conditions like diabetes and hypertension. Additionally, an aging population and escalating stress levels further contribute to the higher incidence of cardiovascular conditions. Implantable cardiac devices are employed to manage and treat conditions such as heart failure, arrhythmias, and coronary artery disease. This heightened requirement accelerates innovation and investment in developing new and improved cardiac devices to cater to the expanding patient population and enhance treatment outcomes. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart disease resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the rising incidence of heart disease drives the growth of the implantable cardiac devices market.

Which Segment Categories Are Driving Maximum Growth In The Implantable Cardiac Devices Market?

The implantable cardiac devicesmarket covered in this report is segmented –

1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)

2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications

3) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers

2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators

3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)

Which Emerging Trends Are Reshaping The Implantable Cardiac Devices Market Landscape?

Companies operating within the implantable cardiac devices market are concentrating on improving compatibility with diagnostic instruments like AutoMRI to extend the operational life of devices and enhance patient safety. The AutoMRI capability in implantable cardiac defibrillators automatically modifies device settings to ensure secure performance during MRI procedures, thereby advancing patient care while facilitating access to sophisticated imaging technology. As an illustration, in October 2023, MicroPort CRM, a medical device company based in France, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These products feature advanced technology designed for low current consumption, contributing to an extended device lifespan and MRI compatibility. The ULYS ICD integrates the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, whereas the INVICTA lead delivers accurate pacing and defibrillation therapy, having achieved a 100% implantation success rate and a 97.4% complication-free rate in clinical studies.

Who Are The Leading Companies Driving The Implantable Cardiac Devices Market?

Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/implantable-cardiac-devices-global-market-report

Which Region Holds The Largest Share In The Implantable Cardiac Devices Market Today?

North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19097&type=smp

Browse Through More Reports Similar to the Global Implantable Cardiac Devices Market 2025, By The Business Research Company

Implantable Cardiac Rhythm Management Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Cardiac Safety Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-safety-services-global-market-report

Cardiac Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795